Federal Register / Vol. 73, No. 157 / Wednesday, August 13, 2008 / Notices 47193 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Medicare & Medicaid 

Services 

[CMS–7011–N] 

Medicare Program: Request for 

Cosponsors for E-prescribing 

Educational Conference 

AGENCY: Centers for Medicare & 

Medicaid Services (CMS), HHS. 

ACTION: Notice. 

SUMMARY: This notice announces the 

opportunity for public and privatesector organizations to act as potential 

cosponsors for a 2-day conference that 

we are sponsoring to educate 

stakeholders about the new eprescribing initiative as described in 

section 132 of the Medicare 

Improvements for Patients and 

Providers Act of 2008. 

DATES: Deadline for Cosponsor 

proposals: Proposals must be received 

no later than Friday, August 15, 2008, 

5 p.m., d.s.t. 

ADDRESSES: Address for Cosponsor 

proposals: Proposals must be sent 

electronically to the following: 

e.prescribing@cms.hhs.gov. 

FOR FURTHER INFORMATION CONTACT: 

Tracy Self, (410) 786–2133, 

Tracy.Self@cms.hhs.gov, or Rachael 

Horvath, (410) 786–7424, 

Rachael.horvath@cms.hhs.gov. 

SUPPLEMENTARY INFORMATION: 

I. Background 

Section 132 of the Medicare 

Improvements for Patients and 

Providers Act of 2008 (MIPPA) (Pub. L. 

110–275) authorizes the Secretary to 

provide incentive payments for 2009 

through 2013 to successful electronic 

prescribers. As described in section 132 

of MIPPA, successful electronic 

prescribers are based on either the 

reporting of applicable electronic 

prescribing measures established under 

the Physician Quality Reporting 

Initiative (PQRI) or through the use of 

Part D data. 

II. Goals of the Conference 

We are sponsoring a 2-day conference 

on October 6 and 7, 2008, from 8:30 a.m. 

to 4:30 p.m. d.s.t. at the Sheraton Boston 

Hotel and Towers, Boston, 

Massachusetts 02199. 

The goals of the conference are to—

• Equip health care professionals and 

other stakeholders with the knowledge 

and the tools to integrate e-prescribing 

into their business model; 

• Generate discussion about the use 

of e-prescribing and other e-health 

initiatives to increase patient 

compliance and overall improved health 

outcomes; 

• Educate health care professionals 

about the structure and the agency’s 

plans for implementation of the 

incentive payment structure in regard to 

e-prescribing and PQRI; 

• Identify and promote opportunities 

to overcome barriers to adoption of this 

new technology; and, 

• Address constituent concerns about 

privacy, security and risk management 

in regard to the implementation of this 

new provision. 

III. Cosponsor Proposals and 

Evaluation Criteria 

This notice is an invitation to submit 

proposals for cosponsorship of the 

conference to the following: interested 

physician and provider organizations 

(including those representing primary 

care, specialty care, surgical and 

medicine-based specialties), not-forprofit organizations representing health 

information networks, health care 

professionals, retail and community 

pharmacies, and organizations 

representing State and local officials. 

Interested parties must submit 

proposals detailing how they will 

support CMS in a nonfiduciary 

relationship by developing conference 

content, identifying speakers, and 

implementing outreach activities to 

educate eligible professionals and 

impacted consumer constituencies 

about the MIPPA provision. 

Each proposal must state that the 

organization has expressed a 

willingness to serve as a cosponsor and 

must be accompanied by documentation 

that indicates said sponsor meets the 

evaluation criteria as described in this 

notice. In order to permit an evaluation 

of possible sources of conflict of 

interest, potential cosponsors may be 

asked to provide detailed information 

concerning financial interests related to 

e-health implementation. 

Cosponsors will be selected based on 

the following evaluation criteria. 

Cosponsors must: 

• Be a non-profit entity representing 

impacted constituencies of eprescribing. 

• Have no direct for-profit interest in 

the implementation of this provision; 

• Demonstrate a substantial interest 

in e-prescribing technology and 

implementation and knowledge of 

current e-prescribing standards for 

Medicare Part D [Note: Documentation 

should include the organization’s goals 

and mission; and details of previous 

activities to support e-prescribing 

including newsletter articles, internet 

sources, research papers, educational 

conferences, public testimony, or other 

similar documentation]; 

• Propose activities and connections 

that are likely to provide a substantial 

public health benefit, consistent with 

HHS goals and the e-prescribing 

initiative including but not limited to 

encouraging attendance through 

member networks, use of cosponsor’s 

logo in support of conference outreach 

and identifying and engaging industry 

leaders for this event; 

• Have the expertise and capacity to 

carry out its proposed activities; and, 

• Demonstrate a willingness to work 

collaboratively with other public and 

private sector organizations to achieve 

the e-health initiatives. 

We will select organizations that meet 

the established evaluation criteria to 

enter into formal cosponsor agreements 

to consult on the conference program 

content, speaker selection, and outreach 

strategies in addition to other tasks as 

described in individual cosponsor 

agreements. Potential cosponsors 

understand that any cosponsor 

agreements will clearly indicate that 

there will be no Federal endorsement of 

the cosponsor or any policies, activities, 

products or services thereof. 

Authority: Sections 1848(k)(6), 

1848(m)(5)(A), and 1851(d) of the Social 

Security Act, 42 U.S.C. 1395(w)–4(k)(6), 42 

U.S.C. 1395(w)–4(m)(5)(A), and 42 U.S.C. 

1395w–21. 

Dated: August 8, 2008. 

Kerry Weems, 

Acting Administrator, Centers for Medicare 

& Medicaid Services. 

[FR Doc. E8–18678 Filed 8–8–08; 12 pm] 

BILLING CODE 4120–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Administration for Children and 

Families 

Submission for OMB Review; 

Comment Request 

Title: Grants to States for Access and 

Visitation: State Child Access Program 

Survey. 

OMB No.: 0970–0204. 

Description: On an annual basis, 

States must provide OCSE with data on 

programs that the Grants to States for 

Access and Visitation Program has 

funded. These program reporting 

requirements include, but are not 

limited to, the collection of data on the 

number of parents served, types of 

services delivered, program outcomes, 

client socio economic data, referrals 

sources, and other relevant data. 


ebenthall on PRODPC60 with NOTICES
47194 Federal Register / Vol. 73, No. 157 / Wednesday, August 13, 2008 / Notices 

Respondents: State Child Access and 

Visitation Programs and State and/or 

local service providers. 

ANNUAL BURDEN ESTIMATES

Instrument Number of respondents 

Number of responses per 

respondent 

Average burden hours per 

response 

Total burden 

hours 

State Child Access Program Survey ............................................................... 314 1 15 4,710 

Estimated Total Annual Burden 

Hours: 4,710. 

Additional Information: Copies of the 

proposed collection may be obtained by 

writing to the Administration for 

Children and Families, Office of 

Administration, Office of Information 

Services, 370 L’Enfant Promenade, SW., 

Washington, DC 20447, Attn: ACE 

Reports Clearance Officer. All requests 

should be 4,710 identified by the title of 

the information collection. E-mail 

address: infocollection@acf.hhs.gov. 

OMB Comment: OMB is required to 

make a decision concerning the 

collection of information between 30 

and 60 days after publication of this 

document in the Federal Register. 

Therefore, a comment is best assured of 

having its full effect if OMB receives it 

within 30 days of publication. Written 

comments and recommendations for the 

proposed information collection should 

be sent directly to the following: Office 

of Management and Budget, Paperwork 

Reduction Project, Fax: 202–395–6974, 

Attn: Desk Officer for the 

Administration for Children and 

Families. 

Dated: August 6, 2008. 

Janean Chambers, 

Reports Clearance Officer. 

[FR Doc. E8–18557 Filed 8–12–08; 8:45 am] 

BILLING CODE 4184–01–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Clinical Center; Notice of Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. Appendix 2), notice 

is hereby given of a meeting of the NIH 

Advisory Board for Clinical Research. 

The meeting will be open to the 

public as indicated below, with 

attendance limited to space available. 

Individuals who plan to attend and 

need special assistance, such as sign 

language interpretation or other 

reasonable accommodations, should 

notify the Contact Person listed below 

in advance of the meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in section 

552b(c)(6), Title 5 U.S.C., as amended to 

discuss personnel matters, the 

disclosure of which would constitute a 

clearly unwarranted invasion of 

personal privacy. 

Name of Committee: NIH Advisory Board 

for Clinical Research. 

Date: September 22, 2008. 

Open: 10 a.m. to 11:30 a.m. 

Agenda: To discuss intramural clinical 

research operational and funding issues. 

Place: National Institutes of Health, 

Building 10, 10 Center Drive, CRC Medical 

Board Room 4–2551, Bethesda, MD 20892. 

Closed: 11:30 a.m. to 1 p.m. 

Agenda: To review and discuss personnel 

matters. 

Place: National Institutes of Health, 

Building 10, 10 Center Drive, CRC Medical 

Board Room 4–2551, Bethesda, MD 20892. 

Contact Person: Maureen E Gormley, 

Executive Secretary, Mark O. Hatfield 

Clinical Research Center, National Institutes 

of Health, Building 10, Room 6–2551, 

Bethesda, MD 20892, 301/496–2897. 

Any interested person may file written 

comments with the committee by forwarding 

the statement to the Contact Person listed on 

this notice. 

The statement should include the name, 

address, telephone number and when 

applicable, the business or professional 

affiliation of the interested person. In the 

interest of security, NIH has instituted 

stringent procedures for entrance onto the 

NIH campus. All visitor vehicles, including 

taxicabs, hotel, and airport shuttles will be 

inspected before being allowed on campus. 

Visitors will be asked to show one form of 

identification (for example, a governmentissued photo ID, driver’s license, or passport) 

and to state the purpose of their visit. 

Dated: August 6, 2008. 

Anna Snouffer, 

Deputy Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. E8–18659 Filed 8–12–08; 8:45 am] 

BILLING CODE 4140–01–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Cancer Institute; Notice of 

Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. Appendix 2), notice 

is hereby given of the meeting of the 

National Cancer Advisory Board. 

The meeting will be open to the 

public as indicated below, with 

attendance limited to space available. 

Individuals who plan to attend and 

need special assistance, such as sign 

language interpretation or other 

reasonable accommodations, should 

notify the Contact Person listed below 

in advance of the meeting. 

A portion of the meeting will be 

closed to the public in accordance with 

the provisions set forth in sections 

552b(c)(4), and 552b(c)(6), Title 5 

U.S.C., as amended. The grant 

applications and the discussions could 

disclose confidential trade secrets or 

commercial property such as patentable 

material, and personal information 

concerning individuals associated with 

the grant applications, the disclosure of 

which would constitute a clearly 

unwarranted invasion of personal 

privacy. 

Name of Committee: National Cancer 

Advisory Board Subcommittee on Cancer 

Centers. 

Open: September 7, 2008, 7:30 p.m. to 

9 p.m. 

Agenda: Discussion on Cancer Centers. 

Place: Bethesda Marriott Suites, 6711 

Democracy Blvd., Bethesda, MD 20817. 

Contact Person: Dr. Paulette S. Gray, 

Executive Secretary, National Cancer 

Institute, National Institutes of Health, 6116 

Executive Boulevard, 8th Floor, Room 8001, 

Bethesda, MD 20892–8327, (301) 496–5147. 

Name of Committee: National Cancer 

Advisory Board 

Open: September 8, 2008, 8 a.m. to 3:15 

p.m. 

Agenda: Program reports and 

presentations; Business of the Board. 

Place: National Cancer Institute, 

9000 Rockville Pike, Building 31, C Wing, 

6th Floor, Conference Room 6, Bethesda, MD 

20892. 


ebenthall on PRODPC60 with NOTICES